| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |